Product Name: Poct Immunoassay Hba1c and Crp Analyzer Ppc 800g Specific Proteins Test Analyzer Model NO.: GR200 Type: Measurement Type Application: Hospital Certification: CE, ISO Material: Plastic Structure: Portable Customized: Non-Customized Trademark: darppon Transport Package: Carton Specification: 40x37X26CM Origin: China Product Description ApplicationThis POCT Immunoassay Quantitative Analyzer supports the reagents like Cardiac Markers,Inflammatory Markers, Inflammatory Markers and ThrombusAdvantages·High standards: quantitative detection, multiple quality control, with the accurate and stable results·High intelligence: automatic identification, full-automated detection with onebutton, Effective docking hospital lis system and automatic uploading data·High efficiency: real-time detection, automatic detection within 20 minutes, realizing fast batch testing·High flexible: a variety of supplementary reagents, covering heart, inflammation, kidney and other fieldsSupporting reagents and clinical application:·Cardiac markersCardiac Troponin I / Myoglobin / Creatine Kinase Isoenzyme MB(cTnI/Myo/CK-MB)Clinical application:Early diagnosis of acute coronary syndrome;The prognosis and risk stratification of acute coronary syndrome evaluation;The forecast of myocardial infarction area;The indicator of thrombolysis and interventional therapy after acute myocardial infarction;Differential diagnosis of chest pain reasons;The evaluation of clinical therapeutic effect.Application department: cardiology department (outpatient clinic, and ward and CCU); emergency department (120 ambulance, ICU); Clinical laboratory, etc.Triad detection, including cTnI, Myo and CK-MB, can effectively avoid missed diagnosis and misdiagnosis.Heart-type fatty acid binding-protein (H-FABP)Clinical application:The earliest sensitive parameter of AMI diagnosis;The forecast of myocardial infarction area;The diagnosis and monitoring of traumatic myocardial injury;Recent predict cardiovascular events after coronary stent.Early detection of H-FABP and Myo, and convalescent of cTnI and CK-MB, is helpful to select high-risk patients with myocardial damage.N-terminal pro-brain B-type natriuretic peptides(NT-proBNP)Clinical application:Prevention and detection of heart failure;Monitoring and evaluation of heart failure therapy;Diagnosis and risk stratification of heart failure;Risk stratification of acute coronary syndrome (ACS);Identification of heart failure and other reasons caused by breathing difficulties.Application department: cardiology department (outpatient clinic, and ward and CCU); emergency department (120 ambulance, ICU); pneumology Department, thoracic surgery, etc.·Inflammatory Markers Procalcitonin(PCT)Clinical application: The identification of bacterial and viral infections;Identification and diagnosis of sepsis, assessment of the severity of the sepsis and disease progression, and prognosis of sepsis judgment;Accurate guidance for the use of antibiotic, avoiding the abuse of antibiotics;The differential diagnosis of fever infection after the surgery, radiotherapy and chemotherapy.Application department: infections department, pediatrics, respiratory infection, emergency department, cardiology, oncology, surgical department, etc.The use of PCT in the sepsis (ICU):PCT< 0.5ng/ml Showing that sepsis is extremely unlikely;PCT> 2 ng/ml Indicating that sepsis could escalate to septic shock.1)PCT guiding the use of antibioticsPCT< 0.1ng/ml Basic without the possibility of bacterial infection, not stronglyrecommend the use of antibiotics;PCT:0.1-0.25ng/ml Bacterial infection is unlikely, whether to use antibioticsshould combined with clinical symptoms;PCT:0.25-0.5ng/ml There may be a need to treat bacterial infections and recommend the use of antibiotics;PCT> 0.5 ng/ml No doubt in need of treatment of bacterial infections, strongly recommend the use of antibiotic.C-reactive protein(hs-CRP+CRP)Clinical application:The identification of bacterial and viral infections;Effect evaluation of antibiotic treatment;The detection and postoperative monitoring in inflammatory disease;The risk of cardiovascular disease and treatment evaluation.Application department: Clinical laboratory, infections department, pediatrics, pneumology department, emergency department, cardiology department, surgical department, etc.Severity judgment of conventional inflammationCRP>50 ug/ml Serious bacterial infection;CRP:20-50 ug/ml General bacterial infections;CRP:10-20 ug/ml Viral or bacterial infection.1)Cardiovascular severe judgmenths CRP<1 ug/ml Low sick;hs CRP :1-3 ug/ml Moderate risk;hs CRP>3 ug/ml Highly dangerous.ThrombusD-DimerClinical application:Exclusion and auxiliary diagnosis of deep venous thrombosis(DVT)and pulmonary embolism(PE);Diagnosis of disseminated intravascular coagulation(DIC);Surgery and thrombolytic therapy monitoring;Diagnosis and detection of high coagulation state of pregnancy-induced hypertension syndrome;Auxiliary diagnosis and prognosis of cerebral infarction.Application department: cardiology department, emergency department, pneumology department, neurology department, surgical department, etc.1)Suspected deep vein thrombosis(DVT)in clinicD-Dimer<0.5 ng/mL,Eliminating DVT;D-Dimer>0.5 ng/mL,Perfoming ultrasonic inspection, if positive, then must be treated with DVT, if negative, considering other clinical possibilities.2)Suspected pulmonary embolism(PE)in clinicD-Dimer<0.5 ng/mL,Eliminating PE;D-Dimer>0.5 ng/mL,Perfoming ultrasonic inspection, if positive, then must be treated with PE, if negative, make a definite diagnosis with ventilation/perfusion scans .